Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer’s disease-Reference-Cited by-同舟云学术

Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer’s disease

Published:2018-12-04 Issue:3 Volume:14 Page:787-796
ISSN:1931-7557
Container-title:Brain Imaging and Behavior
language:en
Short-container-title:Brain Imaging and Behavior

Author:

Vuoksimaa Eero^ORCID, ,McEvoy Linda K.,Holland Dominic,Franz Carol E.,Kremen William S.

Funder

National Institute on Aging

Suomen Aivosäätiö

Terveyden Tutkimuksen Toimikunta

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Psychiatry and Mental health,Cellular and Molecular Neuroscience,Clinical Neurology,Cognitive Neuroscience,Neurology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s11682-018-0019-6.pdf

Reference41 articles.

1. Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., ... Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 7(3), 270–279. https://doi.org/10.1016/j.jalz.2011.03.008 .

2. Apostolova, L. G., Morra, J. H., Green, A. E., Hwang, K. S., Avedissian, C., Woo, E., .... Alzheimer’s Disease Neuroimaging Initiative. (2010). Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. NeuroImage, 51(1), 488–499. https://doi.org/10.1016/j.neuroimage.2009.12.125

3. Bondi, M. W., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., ... Salmon, D. P. (2014). Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. Journal of Alzheimer's Disease : JAD, 42(1), 275–289. https://doi.org/10.3233/JAD-140276 .

4. Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011). Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. Journal of Neuropathology and Experimental Neurology, 70(11), 960–969. https://doi.org/10.1097/NEN.0b013e318232a379 .

5. Chang, Y. L., Bondi, M. W., Fennema-Notestine, C., McEvoy, L. K., Hagler, D. J., Jr, Jacobson, M. W., ... Alzheimer’s Disease Neuroimaging Initiative. (2010). Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer’s disease. Neuropsychologia, 48(5), 1237–1247. https://doi.org/10.1016/j.neuropsychologia.2009.12.024 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporo‐frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: A cross‐cohort comparison;Alzheimer's & Dementia;2024-08-08

2. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease;BMJ Open;2024-06

3. Obesity in Late-Life as a Protective Factor Against Dementia and Dementia-Related Mortality;American Journal of Alzheimer's Disease & Other Dementias®;2023-01

4. Clinical Utility of Cerebrospinal Fluid Aβ42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia;Journal of Alzheimer's Disease;2022-05-17

5. The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer’s Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS);The Journal of Prevention of Alzheimer's Disease;2022